Published October 12, 2017 | Version v1
Journal article Open

Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis

Authors/Creators

  • 1. ROR icon Instituto de Investigación Biomédica de Málaga
  • 2. ROR icon Hospital Infantil Universitario Niño Jesús
  • 3. ROR icon Hospital del Mar Research Institute
  • 4. ROR icon Universidad Complutense de Madrid

Description

Background: Cocaine use disorder (CUD) is a complex health condition, especially when it is accompanied by comorbid psychiatric disorders (dual diagnosis). Dual diagnosis is associated with difficulties in the stratification and treatment of patients. One of the major challenges in clinical practice of addiction psychiatry is the lack of objective biological markers that indicate the degree of consumption, severity of addiction, level of toxicity and response to treatment in patients with CUD. These potential biomarkers would be fundamental players in the diagnosis, stratification, prognosis and therapeutic orientation in addiction. Due to growing evidence of the involvement of the immune system in addiction and psychiatric disorders, we tested the hypothesis that patients with CUD in abstinence might have altered circulating levels of signaling proteins related to systemic inflammation.

Methods: The study was designed as a cross-sectional study of CUD treatment-seeking patients. These patients were recruited from outpatient programs in the province of Malaga (Spain). The study was performed with a total of 160 white Caucasian subjects, who were divided into the following groups: patients diagnosed with CUD in abstinence (N = 79, cocaine group) and matched control subjects (N = 81, control group). Participants were clinically evaluated with the diagnostic interview PRISM according to the DSM-IV-TR, and blood samples were collected for the determination of chemokine C-C motif ligand 11 (CCL11, eotaxin-1), interferon gamma (IFNγ), interleukin-4 (IL-4), interleukin-8 (IL-8), interleukin-17α (IL-17α), macrophage inflammatory protein 1α (MIP-1α) and transforming growth factor α (TGFα) levels in the plasma. Clinical and biochemical data were analyzed in order to find relationships between variables.

Results: While 57% of patients with CUD were diagnosed with dual diagnosis, approximately 73% of patients had other substance use disorders. Cocaine patients displayed greater cocaine symptom severity when they were diagnosed with psychiatric comorbidity. Regarding inflammatory factors, we observed significantly lower plasma levels of IL-17α (p < 0.001), MIP-1α (p < 0.001) and TGFα (p < 0.05) in the cocaine group compared with the levels in the control group. Finally, there was a significant primary effect of dual diagnosis on the plasma concentrations of TGFα (p < 0.05) in the cocaine group, and these levels were lower in patients with dual diagnoses.

Discussion: IL-17α, MIP-1α and TGFα levels are different between the cocaine and control groups, and TGFα levels facilitate the identification of patients with dual diagnosis. Because TGFα reduction is associated with enhanced responses to cocaine in preclinical models, we propose TGFα as a potential biomarker of complex CUD in humans.

Files

PJ MAZA ET AL 2017.pdf

Files (386.5 kB)

Name Size Download all
md5:37de12f3014e7fa21df989996661fe7f
386.5 kB Preview Download

Additional details

Identifiers

PMID
29038767

Related works

Is described by
Journal article: 10.7717/peerj.3926 (DOI)

References

  • Álvarez Y, Pérez-Mañá C, Torrens M, Farré M. Antipsychotic drugs in cocaine dependence: a systematic review and meta-analysis. Journal of Substance Abuse Treatment. 2013;45(1):1–10. doi: 10.1016/j.jsat.2012.12.013.
  • Araos P, Pedraz M, Serrano A, Lucena M, Barrios V, Garcia-Marchena N, Campos-Cloute R, Ruiz JJ, Romero P, Suarez J, Baixeras E, De La Torre R, Montesinos J, Guerri C, Rodriguez-Arias M, Miñarro J, Martinez-Riera R, Torrens M, Chowen JA, Argente J, Mason BJ, Pavon FJ, Fonseca De Rodriguez, F. Plasma profile of proinflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addiction Biology. 2015;20(4):756–772. doi: 10.1111/adb.12156.
  • Balhara YP, Kuppili PP, Gupta R. Neurobiology of comorbid substance use disorders and psychiatric disorders: current state of evidence. Journal of Addictions Nursing. 2017;28(1):11–26. doi: 10.1097/JAN.0000000000000155.
  • Blanco-Calvo E, Rivera P, Arrabal S, Vargas A, Pavón FJ, Serrano A, Castilla-Ortega E, Galeano P, Rubio L, Suárez J, De Fonseca FR. Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rat. Frontiers in Integrative Neuroscience. 2014;8(7) doi: 10.3389/fnint.2013.00106.
  • Castilla-Ortega E, Serrano A, Blanco E, Araos P, Suárez J, Pavón FJ, Rodríguez de Fonseca F, Santín LJ. A place for the hippocampus in the cocaine addiction circuit: potential roles for adult hippocampal neurogenesis. Neuroscience & Biobehavioral Reviews. 2016;66:15–32. doi: 10.1016/j.neubiorev.2016.03.030.
  • Cearley CN, Blindheim K, Sorg BA, Krueger JM, Churchill L. Acute cocaine increases interleukin-1beta mRNA and immunoreactive cells in the cortex and nucleus accumbens. Neurochemical Research. 2011;36:686–692. doi: 10.1007/s11064-011-0410-9.
  • Chahua M, Sánchez-Niubò A, Torrens M, Sordo L, Bravo MJ, Brugal MT, Domingo-Salvany A. Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders. Quality of Life Research. 2015;24(9):2129–2137. doi: 10.1007/s11136-015-0943-5.
  • Chibungu A, Gundareddy V, Wright SM, Nwabuo C, Bollampally P, Landis R, Eid SM. Management of cocaine-induced myocardial infarction: 4-year experience at an urban medical center. Southern Medical Journal. 2016;109(3):185–190. doi: 10.14423/SMJ.0000000000000430.
  • Coller JK, Hutchinson MR. Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacology & Therapeutics. 2012;134(2):219–245. doi: 10.1016/j.pharmthera.2012.01.008.
  • Cooper O, Isacson O. Intrastriatal transforming growth factor α delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. Journal of Neuroscience. 2004;24(41):8924–8931. doi: 10.1523/JNEUROSCI.2344-04.2004. - DOI - PMC - PubMed Cui C, Shurtleff D, Harris RA. Neuroimmune mechanisms of alcohol and drug addiction. International Review of Neurobiology. 2014;118:1–12. doi: 10.1016/B978-0-12-801284-0.00001-
  • Deschaux O, Vendruscolo LF, Schlosburg JE, Diaz-Aguilar L, Yuan CJ, Sobieraj JC, George O. Koob, GF, Mandyam CD. Hippocampal neurogenesis protects against cocaine-primed relapse. Addiction Biology. 2014;19(4):562–574. doi: 10.1111/adb.12019.
  • Engler H, Brendt P, Wischermann J, Wegner A, Röhling R, Schoemberg T, Meyer U, Gold R, Peters J, Benson S, Schedlowski M. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms. Molecular Psychiatry. 2017;22:1448–1454. doi: 10.1038/mp.2016.264.
  • Fanelli MF, Chinen LTD, Begnami MD, Costa WL, Fregnami JHT, Soares FA, Montagnini AL. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial–mesenchymal transition on overall survival of patients with gastric cancer. Histopathology. 2012;61(2):153–161. doi: 10.1111/j.1365-2559.2011.04139.x.
  • Fox HC, D'Sa C, Kimmerling A, Siedlarz KM, Tuit KL, Stowe R, Sinha R. Immune system inflammation in cocaine dependent individuals: implications for medications development. Human Psychopharmacology. 2012;27(2):156–166. doi: 10.1002/hup.1251.
  • García-Marchena N, Araos P, Barrios V, Sánchez-Marín L, Chowen JA, Pedraz M, Castilla-Ortega E, Romero-Sanchiz P, Ponce G, Gavito AL, Decara J, Silva D, Torrens M, Argente J, Rubio G, Serrano A, Rodríguez de Fonseca F, Pavón FJ. Plasma chemokines in patients with alcohol use disorders: association of CCL11 (Eotaxin-1) with psychiatric comorbidity. Front Psychiatry. 2017a;7 doi: 10.3389/fpsyt.2016.00214
  • García-Marchena N, Araos P, Pavón FJ, Ponce G, Pedraz M, Serrano A, Arias F, Romero-Sanchiz P, Suárez J, Pastor A, De la Torre R, Torrens M, Rubio G, Rodríguez de Fonseca F. Psychiatric comorbidity and plasma levels of 2-acyl-glycerols in outpatient treatment alcohol users. Analysis of gender differences. Adicciones. 2017b;29(2):83–96. doi: 10.20882/adicciones.728.
  • Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. The Journal of Clinical Psychiatry. 2009;70(8):1078–1090. doi: 10.4088/JCP.08r04505.
  • González-Saiz F, Vergara-Moragues E, Verdejo-García A, Fernández-Calderón F, Lozano OM. Impact of psychiatric comorbidity on the in-treatment outcomes of cocaine-dependent patients in therapeutic communities. Substance Abuse. 2014;35(2):133–140. doi: 10.1080/08897077.2013.812544.
  • Hasin DS, Trautman KD, Miele GM, Samet S. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. The American Journal of Psychiatry. 1996;153(9):1195–1201. doi: 10.1176/ajp.153.9.1195.
  • Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH, Simon NM. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Research. 2017 doi: 10.1016/j.psychres.2017.01.006
  • Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity. 2007;21(4):374–383. doi: 10.1016/j.bbi.2007.01.010.
  • Irwin MR, Olmos L, Wang M, Valladares EM, Motivala SJ, Fong T, Cole SW. Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. Journal of Pharmacology and Experimental Therapeutics. 2007;320(2):507–515. doi: 10.1124/jpet.106.112797.
  • Köhler CA, Freitas TH, Maes M, De Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanctôt KL, Carvalho AF. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatrica Scandinavica. 2017;135(5):373–387. doi: 10.1111/acps.12698.
  • Levandowski ML, Viola TW, Prado CH, Wieck A, Bauer ME, Brietzke E, Grassi-Oliveira R. Distinct behavioral and immunoendocrine parameters during crack cocaine abstinence in women reporting childhood abuse and neglect. Drug and Alcohol Dependence. 2016;167:140–148. doi: 10.1016/j.drugalcdep.2016.08.010.
  • Li H, Zhang Q, Li N, Wang F, Xiang H, Zhang Z, Su Y, Huang Y, Zhang S, Zhao G, Zhou R, Mao L, Lin Z, Cai W, Fang Y, Xie B, Zhao M, Hong W. Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia. Psychiatry Research. 2016;246:700–706. doi: 10.1016/j.psychres.2016.10.061.
  • Mestre-Pintó JI, Domingo-Salvany A, Martín-Santos R, Torrens M, PsyCoBarcelona Group Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument. European Addiction Research. 2014;20(1):41–48. doi: 10.1159/000351519.
  • Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42(1):254–270. doi: 10.1038/npp.2016.146.
  • Moreira FP, Medeiros JRC, Lhullier AC, De Mattos Souza LD, Jansen K, Portela LV, Lara DR, Da Silva RA, Wiener CD, Oses JP. Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. Drug and Alcohol Dependence. 2016;158:181–185. doi: 10.1016/j.drugalcdep.2015.11.024
  • Morgello S, Holzer 3rd CE, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ. Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. International Journal of Methods in Psychiatric Research. 2006;15(3):131–138. doi: 10.1002/mpr.189.
  • Neupane SP. Neuroimmune interface in the comorbidity between alcohol use disorder and major depression. Frontiers in Immunology. 2016;7 doi: 10.3389/fimmu.2016.00655. Article 625.
  • Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Molecular Psychiatry. 2017 doi: 10.1038/mp.2016.248. Epub ahead of print Jan 17 2017.
  • Ogłodek EA, Szota AM, Just MJ, Moś DM, Araszkiewicz A. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders. Pharmacological Reports. 2015;67(1):85–89. doi: 10.1016/j.pharep.2014.08.006.
  • Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456–1458. doi: 10.1126/science.1202529.
  • Parikh N, Dampier W, Feng R, Passic SR, Zhong W, Frantz B, Blakey B, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Jacobson JM, Wigdahl B. Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort. Journal of Acquired Immune Deficiency Syndromes. 2014;66(3):256–264. doi: 10.1097/QAI.0000000000000163.
  • Pavón FJ, Araos P, Pastor A, Calado M, Pedraz M, Campos-Cloute R, Ruiz JJ, Serrano A, Blanco E, Rivera P, Suárez J, Romero-Cuevas M, Pujadas M, Vergara-Moragues E, Gornemann I, Torrens M, De la Torre R, Rodríguez de Fonseca F. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity. Addiction Biology. 2013;18(6):955–969. doi: 10.1111/adb.12107.
  • Pedraz M, Martín-Velasco AI, García-Marchena N, Araos P, Serrano A, Romero-Sanchiz P, Suárez J, Castilla-Ortega E, Barrios V, Campos-Cloute R, Ruiz JJ, Torrens M, Chowen JA, Argente J, De la Torre R, Santín LJ, Villanúa MÁ, Rodríguez de Fonseca F, Pavón FJ. Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity. PLOS ONE. 2015;10(3):e0118610. doi: 10.1371/journal.pone.0118610. -
  • Petrulli JR, Kalish B, Nabulsi NB, Huang Y, Hannestad J, Morris ED. Systemic inflammation enhances stimulant-induced striatal dopamine elevation. Translational Psychiatry. 2017;7(3):e1076. doi: 10.1038/tp.2017.18. -
  • Piepenbrink MS, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, Kiebala M, Khan AA, Thakar J, Maggirwar SB, Morse D, Rosenberg AF, Haughey NJ, Valenti W, Keefer MC, Kobie JJ. Humoral dysregulation associated with increased systemic inflammation among injection heroin users. PLOS ONE. 2016;11(7):e0158641. doi: 10.1371/journal.pone.0158641.
  • Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunology. 2006;27:24–31. doi: 10.1016/j.it.2005.11.006.
  • Sáez CG, Olivares P, Pallavicini J, Panes O, Moreno N, Massardo T, Mezzano D, Pereira J. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thrombosis Research. 2011;128(4):e18–e23. doi: 10.1016/j.thromres.2011.04.019.
  • Scherer JN, Schuch S, Ornell F, Sordi AO, Bristot G, Pfaffenseller B, Kapczinski F, Kessler FH, Fumagalli F, Pechansky F, Von Diemen L. High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users. Neuroscience Letters. 2016;630:169–175. doi: 10.1016/j.neulet.2016.07.050.
  • Slavich GM. Life stress and health: a review of conceptual issues and recent findings. Teaching of Psychology. 2016;43(4):346–355. doi: 10.1177/0098628316662768.
  • Snyder-Cappione JE, Tincati C, Eccles-James IG, Cappione AJ, Ndhlovu LC, Koth LL, Nixon DF. A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males. PLOS ONE. 2010;5(11):e15412. doi: 10.1371/journal.pone.0015412.
  • Stanwood GD, Levitt P. Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine. Synapse. 2007;61(4):259–262. doi: 10.1002/syn.20364.
  • Stertz L, Magalhaes PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Current Opinion in Psychiatry. 2013;26(1):19–26. doi: 10.1097/YCO.0b013e32835aa4b4.
  • Tarhini AA, Lin Y, Yeku O, La Framboise WA, Ashraf M, Sander C, Lee S, Kirkwood JM. A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma. Journal of Translational Medicine. 2014;12 doi: 10.1186/1479-5876-12-19.
  • Tomasi D, Wang GJ, Wang R, Caparelli EC, Logan J, Volkow ND. Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers. Human Brain Mapping. 2015;36(1):120–136. doi: 10.1002/hbm.22617.
  • Torrens M, Gilchrist G, Domingo-Salvany A, PsyCoBarcelona Group Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug and Alcohol Dependence. 2011;113:147–156. doi: 10.1016/j.drugalcdep.2010.07.013.
  • Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry. 2004;161(7):1231–1237. doi: 10.3109/10826084.2012.663296. -
  • Turiano NA, Mroczek DK, Moynihan J, Chapman BP. Big 5 personality traits and interleukin-6: evidence for "healthy Neuroticism" in a US population sample. Brain, Behavior, and Immunity. 2013;28:83–89. doi: 10.1016/j.bbi.2012.10.020.
  • Van Varsseveld NC, Van Bunderen CC, Sohl E, Comijs HC, Penninx BW, Lips P, Drent ML. Serum insulin-like growth factor 1 and late-life depression: a population-based study. Psychoneuroendocrinology. 2015;54:31–40. doi: 10.1016/j.psyneuen.2015.01.014.
  • Verdejo-Garcia A, Verdejo-Román J, Albein-Urios N, Martínez-González JM, Soriano-Mas C. Brain substrates of social decision-making in dual diagnosis: cocaine dependence and personality disorders. Addiction Biology. 2015;22(2):457–467. doi: 10.1111/adb.12318.
  • Vergara-Moragues E, González-Saiz F, Lozano OM, Betanzos Espinosa P, Fernández Calderón F, Bilbao-Acebos I, Pérez García M, Verdejo García A. Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders. Psychiatry Research. 2012;200(2–3):734–741. doi: 10.1016/j.psychres.2012.07.043.
  • Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, Graves MC, Fiala M. Cocaine opens the blood-brain barrier to HIV-1 invasion. Journal of Neurovirology. 1998;4(6):619–626. doi: 10.3109/13550289809114228.
  • Zimmermann J, Emrich M, Krauthausen M, Saxe S, Nitsch L, Heneka MT, Campbell IL, Müller M. IL-17A promotes granulocyte infiltration, myelin loss, microglia activation, and behavioral deficits during cuprizone-induced demyelination. Molecular Neurobiology. 2017 doi: 10.1007/s12035-016-0368-3. Epub ahead of print Jan 13 2017.